article thumbnail

Reducing Drug Spend with IV Robotic Services

Omnicell

Studies have shown that one out of every ten can put patients at risk. Sterile compounding is also one of the costliest functions in pharmacy operations. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterile compounding operations. 5 at 2 p.m. 5 at 2 p.m. 5 at 2 p.m.

article thumbnail

Despite Safety and Supply Challenges, Outsourcing IV Compounding Remains High

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Unleash Pharmacy Transformation with Intelligent Infrastructure

Omnicell

BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patient care where they can practice at the top of their license.

article thumbnail

Unleash Pharmacy Transformation with Intelligent Infrastructure

Omnicell

BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patient care where they can practice at the top of their license.